GlassScriptPhysician profile
Staci L Capistrano
NPI 1114755840
$2,375.49
in general payments reported to CMS, 2019-2025
19 companies · $2,230 in 2025
The $2,230 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $146 · 2025: $2,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,375.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $388.84 | 2025 | Ozempic, Wegovy |
| Amgen INC. | $331.21 | 2025 | Otezla, Repatha |
| Abbvie INC. | $283.86 | 2025 | |
| Insulet Corporation | $150.00 | 2025 | Omnipod |
| Ucb, INC. | $148.94 | 2025 | Bimzelx |
| Botanix Sb INC | $128.24 | 2025 | Sofdra |
| Janssen Biotech, INC. | $125.00 | 2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2025 | Dupixent |
| Leo Pharma INC. | $125.00 | 2025 | Anzupgo |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Pfizer INC. | $106.09 | 2025 | |
| Sun Pharmaceutical Industries INC. | $62.41 | 2025 | |
| Lilly USA, LLC | $60.12 | 2025 | Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $56.20 | 2025 | |
| Novartis Pharmaceuticals Corporation | $47.19 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $39.68 | 2025 | Ohtuvayre |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $33.17 | 2025 | Caplyta |
| Biofrontera INC. | $20.63 | 2024 | Xepi, Bf-Rhodoled, Rhodoled Xl |
| Exact Sciences Corporation | $18.91 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Staci Capistrano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.